Clinical Trial Update: Ph II Study of Perifosine for Patients With Carcinoma of the Kidney [Phase 2]

View source ↗

Summary

Phase II clinical trial update for perifosine in kidney cancer (carcinoma of the kidney) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• Perifosine (perifosine)

Snippet

Sponsor: AEterna Zentaris | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED